US Stock MarketDetailed Quotes

PRAX Praxis Precision Medicines

Watchlist

41.655
-0.895-2.10%

Trading May 23 14:53 ET

712.63MMarket Cap-3804P/E (TTM)

Praxis Precision Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

36.50%-20.86M

39.94%-111.14M

17.17%-23.86M

48.32%-23.22M

45.44%-31.21M

39.30%-32.85M

-48.56%-185.04M

35.78%-28.81M

-87.46%-44.92M

-90.61%-57.21M

Net income from continuing operations

-5.60%-39.55M

42.40%-123.28M

34.72%-26.88M

43.95%-24.63M

43.00%-34.31M

45.49%-37.46M

-28.11%-214.03M

29.72%-41.17M

1.70%-43.95M

-65.36%-60.19M

Depreciation and amortization

5.66%112K

3.10%432K

5.71%111K

6.86%109K

-10.92%106K

13.98%106K

130.22%419K

12.90%105K

161.54%102K

340.74%119K

Other non cash items

1,255.22%2.72M

11.30%837K

11.22%218K

11.58%212K

10.75%206K

11.67%201K

-46.74%752K

-58.30%196K

-59.31%190K

-36.30%186K

Change In working capital

144.03%1.47M

-687.87%-14.03M

-155.20%-3.04M

43.12%-4.67M

41.97%-2.99M

-154.92%-3.34M

-111.04%-1.78M

-14.31%5.5M

-162.74%-8.21M

-4,581.74%-5.15M

-Change in prepaid assets

-145.62%-808K

1,138.03%6.77M

24.85%-1.34M

104.93%3.29M

71.12%3.05M

266.92%1.77M

109.46%547K

72.75%-1.78M

-62.52%1.6M

219.18%1.78M

-Change in payables and accrued expense

171.25%2.98M

-163.99%-17.35M

-136.76%-925K

24.53%-7.23M

24.20%-5.01M

-158.89%-4.18M

-128.93%-6.57M

-80.95%2.52M

-207.55%-9.58M

-453.34%-6.61M

-Change in other current liabilities

-12.92%-271K

-23.92%-1.01M

-12.02%-261K

-12.39%-254K

23.31%-250K

-823.08%-240K

-6.29%-811K

-18.27%-233K

-17.10%-226K

-73.40%-326K

-Change in other working capital

36.60%-433K

-148.40%-2.45M

-110.30%-515K

---468K

---781K

-1,319.64%-683K

12,431.71%5.06M

9,028.57%5M

--0

Cash from discontinued investing activities

Operating cash flow

36.50%-20.86M

39.94%-111.14M

17.17%-23.86M

48.32%-23.22M

45.44%-31.21M

39.30%-32.85M

-48.56%-185.04M

35.78%-28.81M

-87.46%-44.92M

-90.61%-57.21M

Investing cash flow

Cash flow from continuing investing activities

-368.29%-91.22M

-59.80%38.95M

-100.22%-50K

-85.67%5M

497.66%34M

168.95%96.89M

122.19%22.59M

253.91%47.96M

244.00%34.89M

Net PPE purchase and sale

----

88.74%-50K

---50K

--0

----

57.71%-444K

--0

90.00%-45K

-69.23%-110K

Net investment purchase and sale

-368.29%-91.22M

-59.93%39M

--0

-85.71%5M

511.57%34M

169.79%97.33M

111.16%22.59M

242.86%48M

244.84%35M

Cash from discontinued investing activities

Investing cash flow

-368.29%-91.22M

-59.80%38.95M

-100.22%-50K

--0

-85.67%5M

497.66%34M

168.95%96.89M

122.19%22.59M

253.91%47.96M

244.00%34.89M

Financing cash flow

Cash flow from continuing financing activities

911.38%182.76M

777.89%91.87M

-23.41%4.13M

13,724.40%69.68M

1,394.62%18.07M

-90.27%10.47M

-30.16%5.39M

1,487.26%3.37M

-99.49%504K

Net common stock issuance

909.90%182.75M

857.98%91.59M

-23.05%4.03M

--0

--69.47M

1,222.81%18.1M

-90.96%9.56M

-27.69%5.23M

3,185.42%2.96M

--0

Proceeds from stock option exercised by employees

41.58%143K

-70.83%416K

-34.97%106K

-99.76%1K

-60.00%208K

-69.67%101K

-41.72%1.43M

-65.97%163K

33.12%410K

-35.72%520K

Net other financing activities

-7.87%-137K

73.75%-137K

28.57%-5K

85.71%-1K

75.00%-4K

74.19%-127K

9.22%-522K

---7K

---16K

Cash from discontinued financing activities

Financing cash flow

911.38%182.76M

777.89%91.87M

-23.41%4.13M

--0

13,724.40%69.68M

1,394.62%18.07M

-90.27%10.47M

-30.16%5.39M

1,487.26%3.37M

-99.49%504K

Net cash flow

Beginning cash position

31.73%81.72M

-55.60%62.03M

61.48%101.5M

120.91%124.72M

3.81%81.26M

-55.60%62.03M

-52.99%139.72M

-62.29%62.86M

-68.09%56.46M

-40.59%78.27M

Current changes in cash

267.67%70.68M

125.34%19.69M

-2,298.18%-19.79M

-462.68%-23.22M

299.23%43.46M

131.28%19.22M

50.67%-77.69M

96.94%-825K

162.75%6.4M

-148.32%-21.82M

End cash Position

87.55%152.4M

31.73%81.72M

61.48%101.5M

120.91%124.72M

3.81%81.26M

-55.60%62.03M

-62.29%62.86M

-68.09%56.46M

Free cash flow

36.50%-20.86M

40.06%-111.19M

16.99%-23.91M

48.37%-23.22M

45.54%-31.21M

39.62%-32.85M

-47.68%-185.49M

36.53%-28.81M

-84.19%-44.96M

-90.57%-57.32M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	36.50%-20.86M	39.94%-111.14M	17.17%-23.86M	48.32%-23.22M	45.44%-31.21M	39.30%-32.85M	-48.56%-185.04M	35.78%-28.81M	-87.46%-44.92M	-90.61%-57.21M
Net income from continuing operations	-5.60%-39.55M	42.40%-123.28M	34.72%-26.88M	43.95%-24.63M	43.00%-34.31M	45.49%-37.46M	-28.11%-214.03M	29.72%-41.17M	1.70%-43.95M	-65.36%-60.19M
Depreciation and amortization	5.66%112K	3.10%432K	5.71%111K	6.86%109K	-10.92%106K	13.98%106K	130.22%419K	12.90%105K	161.54%102K	340.74%119K
Other non cash items	1,255.22%2.72M	11.30%837K	11.22%218K	11.58%212K	10.75%206K	11.67%201K	-46.74%752K	-58.30%196K	-59.31%190K	-36.30%186K
Change In working capital	144.03%1.47M	-687.87%-14.03M	-155.20%-3.04M	43.12%-4.67M	41.97%-2.99M	-154.92%-3.34M	-111.04%-1.78M	-14.31%5.5M	-162.74%-8.21M	-4,581.74%-5.15M
-Change in prepaid assets	-145.62%-808K	1,138.03%6.77M	24.85%-1.34M	104.93%3.29M	71.12%3.05M	266.92%1.77M	109.46%547K	72.75%-1.78M	-62.52%1.6M	219.18%1.78M
-Change in payables and accrued expense	171.25%2.98M	-163.99%-17.35M	-136.76%-925K	24.53%-7.23M	24.20%-5.01M	-158.89%-4.18M	-128.93%-6.57M	-80.95%2.52M	-207.55%-9.58M	-453.34%-6.61M
-Change in other current liabilities	-12.92%-271K	-23.92%-1.01M	-12.02%-261K	-12.39%-254K	23.31%-250K	-823.08%-240K	-6.29%-811K	-18.27%-233K	-17.10%-226K	-73.40%-326K
-Change in other working capital	36.60%-433K	-148.40%-2.45M	-110.30%-515K	---468K	---781K	-1,319.64%-683K	12,431.71%5.06M	9,028.57%5M	--0	--0
Cash from discontinued investing activities
Operating cash flow	36.50%-20.86M	39.94%-111.14M	17.17%-23.86M	48.32%-23.22M	45.44%-31.21M	39.30%-32.85M	-48.56%-185.04M	35.78%-28.81M	-87.46%-44.92M	-90.61%-57.21M
Investing cash flow
Cash flow from continuing investing activities	-368.29%-91.22M	-59.80%38.95M	-100.22%-50K	0	-85.67%5M	497.66%34M	168.95%96.89M	122.19%22.59M	253.91%47.96M	244.00%34.89M
Net PPE purchase and sale	----	88.74%-50K	---50K	--0	----	----	57.71%-444K	--0	90.00%-45K	-69.23%-110K
Net investment purchase and sale	-368.29%-91.22M	-59.93%39M	--0	--0	-85.71%5M	511.57%34M	169.79%97.33M	111.16%22.59M	242.86%48M	244.84%35M
Cash from discontinued investing activities
Investing cash flow	-368.29%-91.22M	-59.80%38.95M	-100.22%-50K	--0	-85.67%5M	497.66%34M	168.95%96.89M	122.19%22.59M	253.91%47.96M	244.00%34.89M
Financing cash flow
Cash flow from continuing financing activities	911.38%182.76M	777.89%91.87M	-23.41%4.13M	0	13,724.40%69.68M	1,394.62%18.07M	-90.27%10.47M	-30.16%5.39M	1,487.26%3.37M	-99.49%504K
Net common stock issuance	909.90%182.75M	857.98%91.59M	-23.05%4.03M	--0	--69.47M	1,222.81%18.1M	-90.96%9.56M	-27.69%5.23M	3,185.42%2.96M	--0
Proceeds from stock option exercised by employees	41.58%143K	-70.83%416K	-34.97%106K	-99.76%1K	-60.00%208K	-69.67%101K	-41.72%1.43M	-65.97%163K	33.12%410K	-35.72%520K
Net other financing activities	-7.87%-137K	73.75%-137K	28.57%-5K	85.71%-1K	75.00%-4K	74.19%-127K	9.22%-522K	---7K	---7K	---16K
Cash from discontinued financing activities
Financing cash flow	911.38%182.76M	777.89%91.87M	-23.41%4.13M	--0	13,724.40%69.68M	1,394.62%18.07M	-90.27%10.47M	-30.16%5.39M	1,487.26%3.37M	-99.49%504K
Net cash flow
Beginning cash position	31.73%81.72M	-55.60%62.03M	61.48%101.5M	120.91%124.72M	3.81%81.26M	-55.60%62.03M	-52.99%139.72M	-62.29%62.86M	-68.09%56.46M	-40.59%78.27M
Current changes in cash	267.67%70.68M	125.34%19.69M	-2,298.18%-19.79M	-462.68%-23.22M	299.23%43.46M	131.28%19.22M	50.67%-77.69M	96.94%-825K	162.75%6.4M	-148.32%-21.82M
End cash Position	87.55%152.4M	31.73%81.72M	31.73%81.72M	61.48%101.5M	120.91%124.72M	3.81%81.26M	-55.60%62.03M	-55.60%62.03M	-62.29%62.86M	-68.09%56.46M
Free cash flow	36.50%-20.86M	40.06%-111.19M	16.99%-23.91M	48.37%-23.22M	45.54%-31.21M	39.62%-32.85M	-47.68%-185.49M	36.53%-28.81M	-84.19%-44.96M	-90.57%-57.32M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall